UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Role of c-MYC in alternative activation of human macrophages and tumor-associated macrophage biology

Blood, 2012-01, Vol.119 (2), p.411-421

2012

Volltextzugriff (PDF)

Inhibition of MYC attenuates tumor cell self‐renewal and promotes senescence in SMARCB1‐deficient Group 2 atypical teratoid rhabdoid tumors to suppress tumor growth in vivo

International journal of cancer, 2019-04, Vol.144 (8), p.1983-1995

2019

Volltextzugriff (PDF)

Going for a “KDIP” in colorectal cancer treatment

Clinical and translational discovery, 2022-09, Vol.2 (3), p.n/a

2022

Volltextzugriff (PDF)

Epigenetic SMAD3 Repression in Tumor-Associated Fibroblasts Impairs Fibrosis and Response to the Antifibrotic Drug Nintedanib in Lung Squamous Cell Carcinoma

Cancer research (Chicago, Ill.), 2020-01, Vol.80 (2), p.276-290

2020

Volltextzugriff (PDF)

Biophysical characterization of the b-HLH-LZ of ΔMax, an alternatively spliced isoform of Max found in tumor cells: Towards the validation of a tumor suppressor role for the Max homodimers

PloS one, 2017-03, Vol.12 (3), p.e0174413-e0174413

2017

Volltextzugriff (PDF)

MYC and KRAS cooperation: from historical challenges to therapeutic opportunities in cancer

Signal transduction and targeted therapy, 2024-08, Vol.9 (1), p.205-30

2024

Volltextzugriff (PDF)

MYC: there is more to it than cancer

Frontiers in cell and developmental biology, 2024-03, Vol.12, p.1342872-1342872

2024

Volltextzugriff (PDF)

Pharmacokinetic Analysis of Omomyc Shows Lasting Structural Integrity and Long Terminal Half-Life in Tumor Tissue

Cancers, 2023-01, Vol.15 (3), p.826

2023

Volltextzugriff (PDF)

Finding MYCure

Molecular & cellular oncology, 2019-01, Vol.6 (5), p.e1618178-e1618178

2019

Volltextzugriff (PDF)

Detection of Post-translational Modifications on MYC

Methods in molecular biology (Clifton, N.J.), 2021, Vol.2318, p.69

2021

Volltextzugriff (PDF)

Abstract 2923: Preclinical validation of Omomyc cell-penetrating peptides as a viable in vivo anti-Myc therapy

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.2923-2923

SOUCEK, LAURA

2016

Volltextzugriff (PDF)

Targeting Antitumoral Proteins to Breast Cancer by Local Administration of Functional Inclusion Bodies

Advanced science, 2019-09, Vol.6 (18), p.1900849-n/a

2019

Volltextzugriff (PDF)

Cell-Based Methods for the Identification of Myc-Inhibitory Small Molecules

Methods in molecular biology (Clifton, N.J.), 2021, Vol.2318, p.337

2021

Volltextzugriff (PDF)

Drugging the 'undruggable' cancer targets

Nature reviews. Cancer, 2017-08, Vol.17 (8), p.502-508

2017

Volltextzugriff (PDF)

Editorial overview: Peptides in cancer

Current opinion in pharmacology, 2019-08, Vol.47, p.iii-v

2019

Volltextzugriff (PDF)

Strategies to Inhibit Myc and Their Clinical Applicability

Frontiers in cell and developmental biology, 2017-02, Vol.5, p.10-10

2017

Volltextzugriff (PDF)

The ups and downs of Myc biology

Current opinion in genetics & development, 2010-02, Vol.20 (1), p.91-95

2010

Volltextzugriff (PDF)

Stretching the Limits of Bicyclic Peptides: A Novel Approach to MYC Inhibition and Beyond

GEN biotechnology (Print), 2024-02, Vol.3 (1), p.23-25

2024

Volltextzugriff (PDF)

Bile salt supplementation acts via c-Myc to promote intestinal epithelial proliferation after LPS-induced injury

Journal of the American College of Surgeons, 2011, Vol.213 (3), p.S84-S85

2011

Volltextzugriff (PDF)

MYC inhibitors in multiple myeloma

Cancer Drug Resistance, 2021-01

2021

Volltextzugriff (PDF)

MYC targeting by OMO-103 in solid tumors: a phase 1 trial

Nature medicine, 2024-03, Vol.30 (3), p.762-771

2024

Volltextzugriff (PDF)

eIF4A dependency: the hidden key to unlock KRAS mutant non-small cell lung cancer’s vulnerability

Translational lung cancer research, 2023-12, Vol.12 (12), p.2570-2575

2023

Volltextzugriff (PDF)

Integrated requirement of non‐specific and sequence‐specific DNA binding in Myc‐driven transcription

The EMBO journal, 2021-05, Vol.40 (10), p.e105464-n/a

2021

Volltextzugriff (PDF)

Ibrutinib repurposing: from B-cell malignancies to solid tumors

Oncoscience, 2016-06, Vol.3 (5-6), p.147-148

2016

Volltextzugriff (PDF)

Targeting MYC-driven lymphoma: lessons learned and future directions

Cancer drug resistance, 2023-01, Vol.6 (2), p.205-222

2023

Volltextzugriff (PDF)

1 – 25 von 88

Suche als RSS-Feed

Aktive Filter

ThemaAnimals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(59)
Mit Volltextzugriff
(61)

Publikationsform

Sprache

Englisch
(87)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(49)
Life Sciences & Biomedicine
(43)
Humans
(27)
Cell Biology
(23)
Myc
(19)
Proto-Oncogene Proteins C-Myc - Metabolism
(18)
Genetics & Heredity
(17)
Oncology
(15)
Proto-Oncogene Proteins C-Myc - Genetics
(15)
Cancer
(9)
C-Myc
(6)
Carcinoma, Pancreatic Ductal - Genetics
(6)
Myc Protein
(6)
Pancreatic Neoplasms - Genetics
(6)
Proteins
(6)
Gene Expression
(5)
Genome-Wide Association Study
(5)
Pancreatic Cancer
(5)
Cancer Therapies
(4)
Female
(4)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Role of c-MYC in alternative activation of human macrophages and tumor-associated macrophage biology

Inhibition of MYC attenuates tumor cell self‐renewal and promotes senescence in SMARCB1‐deficient Group 2 atypical teratoid rhabdoid tumors to suppress tumor growth in vivo

Going for a “KDIP” in colorectal cancer treatment

Epigenetic SMAD3 Repression in Tumor-Associated Fibroblasts Impairs Fibrosis and Response to the Antifibrotic Drug Nintedanib in Lung Squamous Cell Carcinoma

Biophysical characterization of the b-HLH-LZ of ΔMax, an alternatively spliced isoform of Max found in tumor cells: Towards the validation of a tumor suppressor role for the Max homodimers

MYC and KRAS cooperation: from historical challenges to therapeutic opportunities in cancer

MYC: there is more to it than cancer

Pharmacokinetic Analysis of Omomyc Shows Lasting Structural Integrity and Long Terminal Half-Life in Tumor Tissue

Finding MYCure

Detection of Post-translational Modifications on MYC

Abstract 2923: Preclinical validation of Omomyc cell-penetrating peptides as a viable in vivo anti-Myc therapy

Targeting Antitumoral Proteins to Breast Cancer by Local Administration of Functional Inclusion Bodies

Cell-Based Methods for the Identification of Myc-Inhibitory Small Molecules

Drugging the 'undruggable' cancer targets

Editorial overview: Peptides in cancer

Strategies to Inhibit Myc and Their Clinical Applicability

The ups and downs of Myc biology

Stretching the Limits of Bicyclic Peptides: A Novel Approach to MYC Inhibition and Beyond

Bile salt supplementation acts via c-Myc to promote intestinal epithelial proliferation after LPS-induced injury

MYC inhibitors in multiple myeloma

MYC targeting by OMO-103 in solid tumors: a phase 1 trial

eIF4A dependency: the hidden key to unlock KRAS mutant non-small cell lung cancer’s vulnerability

Integrated requirement of non‐specific and sequence‐specific DNA binding in Myc‐driven transcription

Ibrutinib repurposing: from B-cell malignancies to solid tumors

Targeting MYC-driven lymphoma: lessons learned and future directions

Aktive Filter

Suchergebnisse filtern